Neurocrine Biosciences (NBIX) Depreciation & Amortization (CF) (2010 - 2026)
Neurocrine Biosciences (NBIX) posted Depreciation & Amortization (CF) of $8.4 million for Q2 2026, up 33.3% from $6.3 million a year earlier and up 16.7% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Neurocrine Biosciences was $28.7 million, up 16.2% year-over-year; for FY2025, it was $26 million, up 10.6% from FY2024.
- Annual Depreciation & Amortization (CF) has increased for 13 consecutive years, with a five-year compound annual growth rate of 24.8% (FY2020 to FY2025).
- In prior years, Neurocrine Biosciences' Depreciation & Amortization (CF) was $23.5 million in FY2024 (+32.0%), $17.8 million in FY2023 (+17.9%), $15.1 million in FY2022 (+38.5%) and $10.9 million in FY2021 (+26.7%).
- The Q2 2026 figure stands as the highest quarterly Depreciation & Amortization (CF) in data going back to Q3 2010.
- On a year-over-year basis, Depreciation & Amortization (CF) has increased in each of the last four quarters, with growth averaging 17.1% over the last eight quarters.
- The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q2 2024, with growth of 52.4%; the weakest was Q2 2025, with a decline of 1.6%.
- According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $7.2 million (Q1 2026), $6.4 million (Q4 2025) and $6.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 194.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 599.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.93 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 98.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.62 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 56.50 Mn |
| 10 | Neurocrine Biosciences | 14.41 Bn | 10.11 Bn | 935.80 Mn | 8.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.40 Mn |
| Mar 31, 2026 | 7.20 Mn |
| Dec 31, 2025 | 6.40 Mn |
| Sep 30, 2025 | 6.70 Mn |
| Jun 30, 2025 | 6.30 Mn |
| Mar 31, 2025 | 6.60 Mn |
| Dec 31, 2024 | 6.20 Mn |
| Sep 30, 2024 | 5.60 Mn |
| Jun 30, 2024 | 6.40 Mn |
| Mar 31, 2024 | 5.30 Mn |
| Dec 31, 2023 | 4.90 Mn |
| Sep 30, 2023 | 4.60 Mn |
| Jun 30, 2023 | 4.20 Mn |
| Mar 31, 2023 | 4.10 Mn |
| Dec 31, 2022 | 3.90 Mn |
| Sep 30, 2022 | 4.00 Mn |
| Jun 30, 2022 | 3.90 Mn |
| Mar 31, 2022 | 3.30 Mn |
| Dec 31, 2021 | 3.00 Mn |
| Sep 30, 2021 | 2.80 Mn |
API Access
Neurocrine Biosciences Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();